The KBCT is the first commercially available three-dimensional (3D) breast CT scanner designed specifically to image the entire breast with a single scan. The device overcomes the current limitations in 2D diagnostic mammography, eliminating overlapping tissue concerns and finally addresses a common patient complaint – breast compression. Through the application of full coverage acquisition at dose levels similar to diagnostic mammography, breast tissue can be reviewed in multiple planes and in genuine 3D reformation.
"The KBCT represents a revolutionary advancement in breast cancer diagnosis. This CFDA approval is a major step forward for breast imaging and women's health care in China," said Ruola Ning, PhD, Koning's president and founder, a pioneer and leading expert in Cone Beam CT Technology and sole inventor of cone beam breast CT technology.